Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review 2019 Conference
25:01

Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignancies

FEATURING Ruemu Birhiray
  • 582 views
  • June 7, 2019
  • 1
20:17

Indy Hematology Review

Therapy for Newly Diagnosed Myeloma - Role of Transplant and MRD, DARA-VRd vs.VRd Trial, Lenalidomide Maintenance Therapy, Achieving MRD- with ASCT and Adding Isatuximab to VRd

FEATURING Kenneth Anderson
  • 452 views
  • June 7, 2019
  • 1
07:23

Indy Hematology Review

Novel Immune Therapies in Myeloma: BCMA Immunotoxin, Bites, and CAR T cells

FEATURING Kenneth Anderson
  • 299 views
  • June 7, 2019
  • 2
06:12

Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of the First MM Platform Trial - MyDRUG

FEATURING Kenneth Anderson
  • 421 views
  • June 24, 2019
  • 3
21:06

Indy Hematology Review

Waldenström's Macroglobulinemia - Novel Therapeutic Approaches Targeting MYD88, CXCR4 Signaling Mutations, New BTK Inhibitors & Related Trials

FEATURING Steven Treon
  • 207 views
  • June 7, 2019
  • 2
14:53

Indy Hematology Review

Treating CLL in 2019: Chemoimmunotherapy is Superior to Chemotherapy and Ibrutinib is More Effective Than Chemoimmunotherapy

FEATURING Jennifer Woyach
  • 355 views
  • June 7, 2019
11:19

Indy Hematology Review

CLL: Should Anyone Still be Treated with Chemoimmunotherapy, Improving Efficacy and Safety of Ibrutinib by Combination or Using Different BTKi

FEATURING Jennifer Woyach
  • 383 views
  • June 7, 2019
  • 2
14:46

Indy Hematology Review

Treatment of Follicular Lymphoma and Other Indolent Lymphomas: Is Targeted Therapy and Immunotherapy More Effective Than Chemo & Novel Targeted Agents

FEATURING Bruce Cheson
  • 682 views
  • June 24, 2019
  • 7
11:53

Indy Hematology Review

Hodgkin Lymphoma - Revolutionized Treatment Options Using Brentuximab Vedotin and Checkpoint Inhibitors

FEATURING Bruce Cheson
  • 393 views
  • June 7, 2019
  • 2
16:17

Indy Hematology Review

Treatment and New Trials in DLBCL - Modifications to R-CHOP Based on Clinical and Pathological Features, Prognostic Significance of MYC, DA-EPOCH-R Therapy

FEATURING John Leonard
  • 223 views
  • June 24, 2019
  • 1
05:14

Indy Hematology Review

Axi cell CAR T-cell Therapy for Refractory DLBCL - Overview of ZUMA-1 and Other Top Trials Presented at ASH

FEATURING John Leonard
  • 191 views
  • June 7, 2019
  • 1
11:24

Indy Hematology Review

Brentuximab Vedotin for Previously Untreated Peripheral T-cell Lymphpoma (ECHELON-2 trial) - New Standard of Care & Mantle Cell Lymphoma - Treatment and Review of Current Trials

FEATURING John Leonard
  • 236 views
  • June 7, 2019
  • 1
14:12

Indy Hematology Review

Immune Thrombocytopenic Purpura (ITP) - Immunopathogenesis, New ASH Draft Guidelines, Which Corticosteroid to Use, Refractory ITP treatment, New TPO - Mimetics

FEATURING Craig Kessler
  • 529 views
  • June 26, 2019
  • 4
21:15

Indy Hematology Review

Pharmacological Landscape of the Direct Oral Anticoagulants - Overview of related trials, DOACs in the Management of Venous Thromboembolism, Idarucizumab, FEIBA and rVIla for DOAC Reversal

FEATURING Craig Kessler
  • 57 views
  • June 26, 2019
08:53

Indy Hematology Review

Follicular Lymphoma Chemo Treatment Regimens - Chemoimmunotherapy, Rituximab Maintenance, Obnituzimab + Chemotherapy

FEATURING Pier Zinzani
  • 151 views
  • June 7, 2019
22:51

Indy Hematology Review

Chemo-free Regimens in Follicular Lymphoma

FEATURING Pier Zinzani
  • 487 views
  • June 28, 2019
18:48

Indy Hematology Review

Starting Therapy in CML - Imatinib Treatment, Early Molecular Response, Reverse Transcription Polymerase Chain Reaction

FEATURING Richard Larson
  • 73 views
  • June 24, 2019
16:19

Indy Hematology Review

CML Treatment - Investigational Agents, Reducing Dosage to Reduce Side-effects & Discontinuation Studies

FEATURING Richard Larson
  • 191 views
  • June 7, 2019
  • 2
27:00

Indy Hematology Review

Acute Myeloid Leukemia - Overview of Available Novel Agents with Unique Mechanisms of Action

FEATURING Martin Tallman
  • 1,783 views
  • June 7, 2019
  • 13
07:47

Indy Hematology Review

Risk Assessment and Genetic Mutations in MDS

FEATURING Richard Stone
  • 85 views
  • June 26, 2019
08:02

Indy Hematology Review

Are There New Approaches in Lower Risk MDS? Overview of Lenalidomide and Luspatercept Trials, Hypomethylating Agents & Spliceosomal Mutations

FEATURING Richard Stone
  • 172 views
  • June 26, 2019
14:27

Indy Hematology Review

Treatment of High Risk MDS: Azacitidine Trials, Immune Checkpoint Inhibitors, Allogeneic Transplant, TP53 Mutations and Iron Chelation Therapy

FEATURING Richard Stone
  • 201 views
  • June 26, 2019
  • 2
19:10

Indy Hematology Review

Allo HSCT: Improvements in Transplant Outcomes, Myeloablative Vs. Reduced-Intensity HCT for AML and MDS, Optimal Haplo Donor

FEATURING Richard Childs
  • 290 views
  • June 26, 2019
  • 1
11:18

Indy Hematology Review

Relapse After Allo HSCT - Treatment Strategies and Overview of Related Studies

FEATURING Richard Childs
  • 130 views
  • June 26, 2019
  • 1
17:35

Indy Hematology Review

Hematopoietic Stem Cell Transplantation: Types of Transplant, Complications, Improvements, Donors & Future Directions

FEATURING Richard Childs
  • 121 views
  • June 28, 2019
08:31

Indy Hematology Review

Art Therapy and Patients With Cancer: Healing Through Creativity

FEATURING Meaghan Wiggins
  • 20 views
  • June 26, 2019
10:17

Indy Hematology Review

Severe Aplastic Anemia: Diagnosis & First Line and Refractory Disease Therapy

FEATURING Robert Brodsky
  • 140 views
  • August 19, 2019
  • 1
06:09

Indy Hematology Review

Paroxysmal Nocturnal Hemoglobinuria (PNH) - Biology, Pathogenesis, Eculizumab trials, Ravulizumab FDA Approval & Next Generation Complement Inhibitors

FEATURING Robert Brodsky
  • 47 views
  • August 19, 2019
09:02

Indy Hematology Review

Molecular Anatomy of MPNs, Scoring Systems & Prognostic Scoring in PV/ET

FEATURING Angela Fleischman
  • 62 views
  • August 19, 2019
16:35

Indy Hematology Review

Review of ASH MPN Therapies: Pegylated Interferon vs. Hydroxyurea & Ruxolitinib Treatment

FEATURING Angela Fleischman
  • 21 views
  • August 19, 2019
23:01

Indy Hematology Review

Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blinatumomab for MRD-Positive ALL

FEATURING Hagop Kantarjian
  • 71 views
  • August 19, 2019
11:11

Indy Hematology Review

Immuno-oncology in ALL - Salvage Standard of Care, Mini-HCVD Plus Ino Plus/Minus Blina, CAR-T to Replace SCT

FEATURING Hagop Kantarjian
  • 31 views
  • August 19, 2019